Clinical Trial Update: Exploratory Study of ZG-801 for the Treatment of Hyperkalemia [Phase 2]

View source ↗

Summary

Exploratory Phase 2 study evaluating ZG-801 for the treatment of hyperkalemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• ZG-801

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Hyperkalemia | Phase 2 | Status: COMPLETED